Compare $INTS vs $VTGN | Chartloom

Compare

$INTS vs $VTGN

Intensity Therapeutics Inc · Vistagen Therapeutics Inc

INTS

Intensity Therapeutics Inc

VTGN

Vistagen Therapeutics Inc

Compare $INTS vs $VTGN

Comparing Intensity Therapeutics Inc and Vistagen Therapeutics Inc

INTSIntensity Therapeutics Inc

VTGNVistagen Therapeutics Inc

INTSIntensity Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-64.3%

52W performance

-49.1%

FCF yield

-91.4%

VTGNVistagen Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

278.5%

YTD performance

-65.2%

52W performance

-94.1%

FCF yield

-644.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INTS

VTGN

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

INTS$10M

VTGN$10M

Enterprise Value

INTS$272K

VTGN$-7M

Price

INTS$3.63

VTGN$0.24

P/E Ratio

INTSN/A

VTGNN/A

P/S Ratio

INTS0.00x

VTGN3.87x

EV/Sales

INTS0.00x

VTGN-2.92x

EV/EBITDA

INTS0.00x

VTGN0.00x

P/B Ratio

INTS1.22x

VTGN0.56x

P/FCF Ratio

INTSN/A

VTGNN/A

EV/FCF

INTS-0.03x

VTGN0.12x

PEG Ratio

INTSN/A

VTGNN/A

Forward P/E (NTM)

INTSN/A

VTGNN/A

Forward P/S (NTM)

INTSN/A

VTGNN/A

Revenue (TTM)

INTS$0

VTGN$3M

Revenue Growth (YoY)

INTSN/A

VTGN278.5%

Forward Rev Growth

INTS506.0%

VTGN4633.2%

Gross Margin (TTM)

INTS0.0%

VTGN0.0%

Operating Margin (TTM)

INTS0.0%

VTGN0.0%

EBITDA Margin (TTM)

INTS0.0%

VTGN-2775.9%

Net Margin (TTM)

INTS0.0%

VTGN-2702.6%

FCF Margin (TTM)

INTSN/A

VTGN-2493.3%

Net Income (TTM)

INTS$-11M

VTGN$-68M

FCF (TTM)

INTS$-9M

VTGN$-62M

EPS (TTM)

INTS-$4.12

VTGN-$1.57

ROE (TTM)

INTS-11661.0%

VTGN-15259.0%

ROA (TTM)

INTS-9401.0%

VTGN-11745.0%

ROIC (TTM)

INTS-11661.0%

VTGN-15162.0%

Cash

INTS$10M

VTGN$17M

Debt

INTS$0

VTGN$0

Net Cash/Debt

INTS$10M

VTGN$17M

Current Ratio (TTM)

INTS5.00x

VTGN3.07x

Quick Ratio (TTM)

INTS4.24x

VTGN2.84x

Debt/Equity (TTM)

INTS0.00x

VTGN0.00x

Debt/Assets (TTM)

INTS0.0%

VTGN0.0%

Interest Coverage (TTM)

INTSN/A

VTGNN/A

Net Debt/EBITDA (TTM)

INTS0.00x

VTGN0.00x

Beta

INTS3.02

VTGN0.49

52W Performance

INTS-49.1%

VTGN-94.1%

YTD Performance

INTS-64.3%

VTGN-65.2%

% from 52W High

INTS-91.7%

VTGN-95.4%

% from 52W Low

INTS13.1%

VTGN19.2%

Asset Turnover (TTM)

INTS0.00x

VTGN0.04x

FCF Yield (TTM)

INTS-91.4%

VTGN-644.0%

Earnings Yield (TTM)

INTS-113.9%

VTGN-698.0%

Dividend Yield (TTM)

INTSN/A

VTGNN/A

Rule of 40

INTS0.0

VTGN-2,214.8

EV/GP/RG

INTSN/A

VTGNN/A

Ticker research

View INTS research View VTGN research

Metric	INTS Intensity Therapeutics Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$272K	$-7M
Price	$3.63	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.87x
EV/Sales	0.00x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	506.0%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2775.9%
Net Margin (TTM)	0.0%	-2702.6%
FCF Margin (TTM)	N/A	-2493.3%
Net Income (TTM)	$-11M	$-68M
FCF (TTM)	$-9M	$-62M
EPS (TTM)	-$4.12	-$1.57
ROE (TTM)	-11661.0%	-15259.0%
ROA (TTM)	-9401.0%	-11745.0%
ROIC (TTM)	-11661.0%	-15162.0%
Financial Health
Cash	$10M	$17M
Debt	$0	$0
Net Cash/Debt	$10M	$17M
Current Ratio (TTM)	5.00x	3.07x
Quick Ratio (TTM)	4.24x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	0.49
52W Performance	-49.1%	-94.1%
YTD Performance	-64.3%	-65.2%
% from 52W High	-91.7%	-95.4%
% from 52W Low	13.1%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-91.4%	-644.0%
Earnings Yield (TTM)	-113.9%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View VTGN research

Valuation

P/S Ratio

INTS

0.00x

VTGN

3.87x

EV/FCF

INTS

-0.03x

VTGN

0.12x

Growth & revenue

Revenue Growth TTM

VTGN

278.5%

Forward Revenue Growth

VTGN

4633.2%

INTS

506.0%

Profitability & performance

Gross Margin

INTS

0.0%

VTGN

0.0%

ROE

INTS

-11661.0%

VTGN

-15259.0%

FCF Yield %

INTS

-91.4%

VTGN

-644.0%

52-Week Performance

INTS

-49.1%

VTGN

-94.1%

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

INTS$10M

VTGN$10M

Enterprise Value

INTS$272K

VTGN$-7M

Price

INTS$3.63

VTGN$0.24

P/E Ratio

INTSN/A

VTGNN/A

P/S Ratio

INTS0.00x

VTGN3.87x

EV/Sales

INTS0.00x

VTGN-2.92x

EV/EBITDA

INTS0.00x

VTGN0.00x

P/B Ratio

INTS1.22x

VTGN0.56x

P/FCF Ratio

INTSN/A

VTGNN/A

EV/FCF

INTS-0.03x

VTGN0.12x

PEG Ratio

INTSN/A

VTGNN/A

Forward P/E (NTM)

INTSN/A

VTGNN/A

Forward P/S (NTM)

INTSN/A

VTGNN/A

Revenue (TTM)

INTS$0

VTGN$3M

Revenue Growth (YoY)

INTSN/A

VTGN278.5%

Forward Rev Growth

INTS506.0%

VTGN4633.2%

Gross Margin (TTM)

INTS0.0%

VTGN0.0%

Operating Margin (TTM)

INTS0.0%

VTGN0.0%

EBITDA Margin (TTM)

INTS0.0%

VTGN-2775.9%

Net Margin (TTM)

INTS0.0%

VTGN-2702.6%

FCF Margin (TTM)

INTSN/A

VTGN-2493.3%

Net Income (TTM)

INTS$-11M

VTGN$-68M

FCF (TTM)

INTS$-9M

VTGN$-62M

EPS (TTM)

INTS-$4.12

VTGN-$1.57

ROE (TTM)

INTS-11661.0%

VTGN-15259.0%

ROA (TTM)

INTS-9401.0%

VTGN-11745.0%

ROIC (TTM)

INTS-11661.0%

VTGN-15162.0%

Cash

INTS$10M

VTGN$17M

Debt

INTS$0

VTGN$0

Net Cash/Debt

INTS$10M

VTGN$17M

Current Ratio (TTM)

INTS5.00x

VTGN3.07x

Quick Ratio (TTM)

INTS4.24x

VTGN2.84x

Debt/Equity (TTM)

INTS0.00x

VTGN0.00x

Debt/Assets (TTM)

INTS0.0%

VTGN0.0%

Interest Coverage (TTM)

INTSN/A

VTGNN/A

Net Debt/EBITDA (TTM)

INTS0.00x

VTGN0.00x

Beta

INTS3.02

VTGN0.49

52W Performance

INTS-49.1%

VTGN-94.1%

YTD Performance

INTS-64.3%

VTGN-65.2%

% from 52W High

INTS-91.7%

VTGN-95.4%

% from 52W Low

INTS13.1%

VTGN19.2%

Asset Turnover (TTM)

INTS0.00x

VTGN0.04x

FCF Yield (TTM)

INTS-91.4%

VTGN-644.0%

Earnings Yield (TTM)

INTS-113.9%

VTGN-698.0%

Dividend Yield (TTM)

INTSN/A

VTGNN/A

Rule of 40

INTS0.0

VTGN-2,214.8

EV/GP/RG

INTSN/A

VTGNN/A

Ticker research

View INTS research View VTGN research

Metric	INTS Intensity Therapeutics Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$272K	$-7M
Price	$3.63	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.87x
EV/Sales	0.00x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	506.0%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2775.9%
Net Margin (TTM)	0.0%	-2702.6%
FCF Margin (TTM)	N/A	-2493.3%
Net Income (TTM)	$-11M	$-68M
FCF (TTM)	$-9M	$-62M
EPS (TTM)	-$4.12	-$1.57
ROE (TTM)	-11661.0%	-15259.0%
ROA (TTM)	-9401.0%	-11745.0%
ROIC (TTM)	-11661.0%	-15162.0%
Financial Health
Cash	$10M	$17M
Debt	$0	$0
Net Cash/Debt	$10M	$17M
Current Ratio (TTM)	5.00x	3.07x
Quick Ratio (TTM)	4.24x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	0.49
52W Performance	-49.1%	-94.1%
YTD Performance	-64.3%	-65.2%
% from 52W High	-91.7%	-95.4%
% from 52W Low	13.1%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-91.4%	-644.0%
Earnings Yield (TTM)	-113.9%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View VTGN research